Archives

StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Has Your Insurance Company Forced You to Change Medications?

We’re hearing more and more stories about insurance companies forcing patients to change from medications they are doing well on to less expensive medications, in spite of their wishes or those of their doctors. While that usually is not a problem, we’re hearing about more and more adverse events resulting from these medication changes (non-medical …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Top Things You Need to Know When Taking an Anticoagulant – Video

StopAfib.org participated in a video series for those living with afib. The latest video, The Top Things You Need to Know When Taking an Anticoagulant, was released on September 29 for World Heart Day. To learn more, and watch the video, go to: StopAfib.org Participates in New Video Series About Atrial Fibrillation and Stroke Risk

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

ESC: New Anticoagulant, Edoxaban, Safer Than Warfarin

We’re finally getting a glimpse into what to expect from edoxaban, the 4th new anticoagulant medication. At the European Society of Cardiology in Amsterdam, it was reported that edoxaban was safer--in other words, had less bleeding--than warfarin for those with deep vein thrombosis (blood clots in the legs) or pulmonary embolism (blood clots in the …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Why You Shouldn’t Use Aspirin for Atrial Fibrillation Stroke Prevention — Video with Dr. Waldo

At Heart Rhythm 2012, Dr. Albert Waldo shared with StopAfib.org’s Mellanie True Hills about why aspirin should no longer be used for the prevention of stroke in atrial fibrillation. Dr. Waldo noted that many global afib guidelines have been revised, or soon will be, to remove aspirin as a recommended atrial fibrillation stroke prevention treatment. …

Read More

Atrial Fibrillation & Anticoagulants–StopAfib.org interviews Dr. Daniel Singer

StopAfib.org interviews Dr. Daniel Singer of Harvard Medical School. Find more information on this topic, and Dr. Singer, at: http://www.stopafib.org/newsitem.cfm/NEWSID/397 Dr. Singer led a symposium on atrial fibrillation stroke prevention at Boston Atrial Fibrillation Symposium 2012. In this video interview, Dr. Singer shared with StopAfib.org information from that symposium. He provided an update on rivaroxaban …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Update on Atrial Fibrillation Stroke Prevention — Video interview with Dr. Daniel Singer of Harvard

In this interview, Dr. Daniel Singer updates us on the new anticoagulants for atrial fibrillation stroke prevention that he presented about at Boston Atrial Fibrillation Symposium. He provided an update on rivaroxaban (Xarelto), apixaban (Eliquis), dabigatran (Pradaxa), and edoxaban, and mentioned that all were better than warfarin (Coumadin) in preventing intracranial bleeding (bleeding in the …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Guest Post by Dr. John Mandrola: More Dabigatran (Pradaxa) News

Dr. John Mandrola shares a great update on the latest info regarding dabigatran (Pradaxa, Pradax). Dr. Mandrola not only treats atrial fibrillation patients, but he has also experienced afib himself. I have become an AF-doctor. That means my most exciting aspect of medicine is terminating AF with watts delivered through a catheter. “Got it.” In …

Read More
Hispanic grandfather

Mexican Americans with Atrial Fibrillation (AF) Have More and Worse Strokes

A new study exploring ethnic differences in stroke risk for people with atrial fibrillation (AF) showed that Mexican American stroke survivors with afib were more than twice as likely to have another stroke as comparable non-Hispanic white stroke survivors with afib. Researchers were surprised by the study’s finding that severity of recurrent stroke is also …

Read More